Efficacy of infliximab treatment in patients with early and long-standing juvenile idiopathic arthritis

被引：0
|
作者：
Sleptsova, Tatyana
Alexeyeva, Ekaterina
Valiyeva, Sanya
Bzarova, Tatyana
Chistyakova, Evgeniya
Denisova, Rina
Lisicin, Alexander
Isayeva, Xenia
Mitenko, Elena
机构：
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2011年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：460 / 461
页数：2
相关论文
共 50 条
  • [31] Long-term evaluation of efficacy and safety of infliximab in the treatment of persistently active juvenile idiopathic arthritis (JIA), refractory to standard treatments
    Gerloni, V
    Pontikaki, I
    De Marco, G
    Valcamonica, E
    Gattinara, M
    Teruzzi, B
    Lurati, A
    Salmaso, A
    Fantini, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 515 - 515
  • [32] Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis?
    Ting, T. V.
    Lovell, D. J.
    Levinson, Joseph E.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (07): : 344 - 345
  • [33] Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis?
    Tracy V Ting
    Daniel J Lovell
    Nature Clinical Practice Rheumatology, 2008, 4 : 344 - 345
  • [34] Efficacy and safety of over 8 years of etanercept (ENBREL®) therapy in north American patients with early and long-standing rheumatoid arthritis
    Weinblatt, M. E.
    Genovese, M. C.
    Moreland, L. W.
    Bathon, J. M.
    Kremer, J. M.
    Fleischmann, R. M.
    Schiff, M. H.
    Chon, Y.
    Peloso, P.
    White, B.
    Ratnasingham, L.
    RHEUMATOLOGY, 2006, 45 : I44 - I45
  • [35] Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept
    Katsicas, MM
    Russo, RAG
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) : 545 - 548
  • [36] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    María M. Katsicas
    Ricardo A. G. Russo
    Clinical Rheumatology, 2009, 28 : 985 - 988
  • [37] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and infliximab
    Katsicas, M. M.
    Russo, R. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 551 - 552
  • [38] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    Katsicas, Maria M.
    Russo, Ricardo A. G.
    CLINICAL RHEUMATOLOGY, 2009, 28 (08) : 985 - 988
  • [39] Impact of Adalimumab Therapy On Laboratory Parameters of Interest in Patients with Early or Long-Standing Rheumatoid Arthritis
    Furst, De
    Lacerda, Ana P.
    Andhivarothai, Nupun
    Kalabic, Jasmina
    Mozaffarian, Neelufar
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S211 - S212
  • [40] Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients
    NM Wulffraat
    N Ruperto
    HI Brunner
    S Oliveira
    Y Uziel
    K Nistala
    R Cimaz
    MA Ferrandiz
    B Flato
    M Gamir
    I Kone-Paut
    C Gaillez
    K Lheritier
    K Abrams
    A Martini
    D Lovell
    Pediatric Rheumatology, 12 (Suppl 1)
12345